Hsiao D. Lieu

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial

Ami E. Iskandrian, Timothy M. Bateman, Luiz Belardinelli et al. · Journal of Nuclear Cardiology · 2007 · 341 citations

Multicenter International Trial, Radiology, Health Sciences +12

Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis

Stephen A. Harrison, Guy Neff, Cynthia D. Guy et al. · Gastroenterology · 2020 · 257 citations · Full text

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Hsiao D. Lieu, John C. Shryock, Gregory O. von Mering et al. · Journal of Nuclear Cardiology · 2007 · 138 citations

Thrombosis, Cardiovascular Disease, Medicine +10

Eliminating Atherogenesis in Mice by Switching Off Hepatic Lipoprotein Secretion

Hsiao D. Lieu, Shannon K. Withycombe, Quinn M. Walker et al. · Circulation · 2003 · 118 citations

Pharmacodynamics Pharmacodynamics of a Novel Designer Natriuretic Peptide, CD‐NP, in a First‐in‐Human Clinical Trial in Healthy Subjects

Candace Y.W. Lee, Horng H. Chen, Ondřej Lisý et al. · The Journal of Clinical Pharmacology · 2009 · 108 citations · Full text

Hypertension, Heart Failure, Healthy Subjects +18